Kodiak Sciences (KOD) Amortizatization of Intangibles (2019 - 2026)
Kodiak Sciences (KOD) reported Amortizatization of Intangibles of $2.2 million for Q1 2026, up 4.99% on a YoY basis from $2.1 million in Q1 2025, and up 13.19% quarter-over-quarter from $2.0 million in Q4 2025.
Kodiak Sciences (KOD) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Kodiak Sciences has reported Amortizatization of Intangibles for 8 years, with the latest figure at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 4.99% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.1 million (up 4349.45% YoY), and the FY2025 full-year result was $8.0 million, changed N/A from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $2.2 million, up from $2.0 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $3.2 million in Q2 2023, with the low at -$5.9 million in Q4 2024.
- Historically, Amortizatization of Intangibles has averaged $758562.5 across 5 years, with a median of $1.9 million in 2024.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles plunged 95.86% — and 2024, when it soared 275.1%.
- Kodiak Sciences' Amortizatization of Intangibles stood at $320000.0 in 2022, then slumped by 1005.94% to -$2.9 million in 2023, then tumbled by 104.9% to -$5.9 million in 2024, then soared by 133.18% to $2.0 million in 2025, then advanced by 13.19% to $2.2 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.2 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 2.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.23 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | -5.94 Mn |
| Dec 31, 2024 | -5.94 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Sep 30, 2023 | -2.90 Mn |
| Sep 30, 2023 | -2.90 Mn |